Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Utah Medical Products (UTMD) Net Cash Flow (2016 - 2025)

Utah Medical Products (UTMD) has 16 years of Net Cash Flow data on record, last reported at $2.2 million in Q3 2025.

  • For Q3 2025, Net Cash Flow rose 292.01% year-over-year to $2.2 million; the TTM value through Sep 2025 reached -$4.2 million, down 1781.33%, while the annual FY2024 figure was -$9.2 million, 152.73% down from the prior year.
  • Net Cash Flow reached $2.2 million in Q3 2025 per UTMD's latest filing, up from -$1.7 million in the prior quarter.
  • Across five years, Net Cash Flow topped out at $5.8 million in Q1 2023 and bottomed at -$4.8 million in Q4 2024.
  • Average Net Cash Flow over 5 years is $1.8 million, with a median of $3.4 million recorded in 2021.
  • Peak YoY movement for Net Cash Flow: surged 307.91% in 2021, then crashed 226.79% in 2024.
  • A 5-year view of Net Cash Flow shows it stood at -$3.3 million in 2021, then soared by 241.55% to $4.7 million in 2022, then fell by 11.67% to $4.2 million in 2023, then tumbled by 215.54% to -$4.8 million in 2024, then soared by 145.86% to $2.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Net Cash Flow were $2.2 million in Q3 2025, -$1.7 million in Q2 2025, and $42000.0 in Q1 2025.